Editorial
Published on 10 Nov 2022
Editorial: Advances in non-alcoholic fatty liver disease therapeutics: Pathogenic mechanisms and targets
in Gastrointestinal and Hepatic Pharmacology
- 841 views
Editorial
Published on 10 Nov 2022
in Gastrointestinal and Hepatic Pharmacology
Review
Published on 10 Nov 2022
in Gastrointestinal and Hepatic Pharmacology
Correction
Published on 10 Nov 2022
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 09 Nov 2022
in Gastrointestinal and Hepatic Pharmacology
Editorial
Published on 09 Nov 2022
in Gastrointestinal and Hepatic Pharmacology
Review
Published on 08 Nov 2022
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 08 Nov 2022
in Gastrointestinal and Hepatic Pharmacology
Review
Published on 02 Nov 2022
in Gastrointestinal and Hepatic Pharmacology
Review
Published on 01 Nov 2022
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 28 Oct 2022
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 28 Oct 2022
in Gastrointestinal and Hepatic Pharmacology
Review
Published on 28 Oct 2022
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 25 Oct 2022
in Gastrointestinal and Hepatic Pharmacology
Review
Published on 25 Oct 2022
in Gastrointestinal and Hepatic Pharmacology
Review
Published on 25 Oct 2022
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 24 Oct 2022
in Gastrointestinal and Hepatic Pharmacology